Fabien de Ladonchamps
Director Ejecutivo en OBSEVA SA .
Origen de la red de primer grado Fabien de Ladonchamps.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
27
| Public Company | Pharmaceuticals: Major | 27 |
| Public Company | Pharmaceuticals: Major | 16 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Fabien de Ladonchamps a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Chairman | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chairman Private Equity Investor Chief Operating Officer | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Chairman Founder | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal | |
| SYNLOGIC, INC. | Biotechnology | President Director/Board Member | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Geneva | College/University | Undergraduate Degree Doctorate Degree | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Chairman Investment Committee Member | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Chief Executive Officer | |
| Sonrgy, Inc. | Chief Executive Officer | ||
TA SASU
 TA SASU Pharmaceuticals: MajorHealth Technology Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Decoy Biosystems, Inc.
 Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
| FEINTOOL INTERNATIONAL HOLDING AG | Metal Fabrication | Chief Executive Officer | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PharmaSens AG
 PharmaSens AG Medical SpecialtiesHealth Technology PharmaSens AG develops medical devices for diabetes care. The private company is based in Reinach, Switzerland. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 23 |
| Suiza | 10 |
| Francia | 7 |
| Reino Unido | 5 |
| Bélgica | 3 |
Sectorial
| Health Technology | 40 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Finance | 2 |
| Producer Manufacturing | 2 |
Operativa
| Director/Board Member | 315 |
| Corporate Officer/Principal | 110 |
| Independent Dir/Board Member | 95 |
| Chairman | 47 |
| Chief Executive Officer | 33 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Healy | 50 |
| Antoine Papiernik | 48 |
| Ed Mathers Mathers | 47 |
| Ho Young Huh | 32 |
| Bharatt Chowrira | 24 |
| Rafaèle Elisabeth Tordjman | 23 |
| Beat E. Lüthi | 23 |
| Anne VanLent | 23 |
| Barbara Duncan | 22 |
| Brian O'Callaghan | 20 |
| Graham Dixon | 18 |
| Ray Hill | 18 |
| Tim Adams | 17 |
| Frank Verwiel | 16 |
| Elizabeth Garner | 15 |
- Bolsa de valores
- Insiders
- Fabien de Ladonchamps
- Conexiones Empresas